饮食中的黄素,特别是阿皮基宁和黄素与表型衰老加速的关联:使用NHANES数据的横截面研究
Xiaoqiao Wang1, Chang Liu, Guixia Li
1Department of Nephrology, Shenzhen Third People's Hospital, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
Medicine
|December 16, 2025
概括
饮食中摄入较高的类黄素,如阿皮基宁和白素,与缓慢的生物衰老有关. 这表明黄可能通过其抗炎和抗氧化作用促进健康的衰老.
科学领域:
- 营养流行病学 营养流行病学
- 生物遗传学 生物遗传学
- 分子营养分子营养学
背景情况:
- 类黄,如阿皮基宁和黄素,具有与衰老相关的已知的抗炎和抗氧化特性.
- 目前,将弗拉消费与表型衰老加速 (PhenoAgeAccel) 联系起来的流行病学数据有限.
研究的目的:
- 为了研究饮食中的黄摄入量与PhenoAgeAccel在美国成年人群中存在的关联,在一个庞大的,具有全国代表性的美国成年人群中.
- 探索与PhenoAgeAccel相关的阿皮基宁和白素的特定作用.
主要方法:
- 来自国家健康和营养检查调查 (2007-2010年和2017-2018年) 的10,789名美国成年人的数据分析.
- PhenoAgeAccel计算为从回归的表型年龄到时间年龄的剩余值.
- 通过24小时回忆评估饮食摄入量;统计分析包括加权多变量逻辑回归和受限立方线.
主要成果:
- 较高的总黄摄入量显示PhenoAgeAccel的剂量依赖性显著下降 (P趋势<.001).
- 增加的弗拉摄入量与PhenoAgeAccel的几率降低有关,与阿皮根因和黄素的类似反向关联有关.
- 对于所有黄素,观察到显著的非线性剂量反应关系,在人口统计和健康亚组中发现一致的结果.
结论:
- 饮食中较高的黄摄入量,特别是阿皮基宁和黄素,与美国成年人的PhenoAgeAccel降低密切相关.
- 这些发现强调了黄作为可修改的饮食因素的潜力,有助于健康的衰老.
- 进一步的研究可以探索这些关联及其临床影响背后的机制.
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
208
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
208
The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181


